Donate
  • Freedom
  • Innovation
  • Growth

Intellectual Property

Intellectual Property RSS Feed

Economic growth begins with ideas, innovation and creativity. Since the signing of the Constitution, the U.S. has protected the fruits of creativity and innovation through intellectual property protection, primarily expressed as patents, trademarks, copyright and trade secrets.

As our economy has become even more dependent on innovation, intellectual property issues have been pushed to the forefront. The clashes have led some to question the value and even the legitimacy of IP protection. While some of these attacks come from the libertarian perspective, most originate from the same naïve socialist impulses that so demonstrably failed in the realm of real property—but somehow are seen as thoughtful with respect to IP.

IPI believes that creators have the right to own and control the fruits of their creativity, and that the IP system has done an admirable job of not only incentivizing innovation, but also making creative products and services available to the public and transferring technology to the developing world.

August 4, 2020

Covid-19 Proves Patents and Competition Are Compatible

The race to create a Covid-19 vaccine and treatment is proving that drug company patents do not stifle competition—they only stifle copying.

July 24, 2020

IPI Opposes IPI: Problems with a Prescription Drug Pricing Index

IPI urges the Trump administration to forbear importing the price controls of socialist health care systems to the U.S.

June 16, 2020

Why All the Handwringing Over a COVID-19 Vaccine's Effectiveness?

Before we demand that a COVID-19 vaccine "prevents" contracting the disease in all cases, consider the flu vaccine.

June 1, 2020

Attempts to Degrade Drug Patents are Counterproductive in This Pandemic

Compulsory licensing deters innovators from investing in drug discovery. It won’t reduce what patients pay.

May 6, 2020

Coalition Letter Regarding Intellectual Property of COVID-19 Research

Coalition letter in opposition to lawmakers actions that would deny patents, exclusivity, and property rights to biomedical innovators working on vaccines, diagnostics, therapies, and cures for COVID-19.

February 18, 2020

What Foreign Steel, NATO and Prescription Drugs Have in Common

If the president doesn't want to import price-controlled, foreign-made steel, then why does he want to import price-controlled prescription drugs? 

February 12, 2020

Why Is the U.S. Surrendering the Global IP System to China?

Only immediate attention from the White House can prevent WIPO from becoming dominated by China, which would pose risks to the entire global IP system, and thus to U.S. security and innovation.

January 28, 2020

'Greedy' Drugmakers Pour Money into Finding a Coronavirus Fix

Governments can't act as quickly as private sector drug companies when it comes to finding a vaccine for the coronavirus or any other epidemic.

October 23, 2019

How Those Memes You Just Posted Could Soon Cost You $30,000

You’re served with a notice. Apparently you’d shared some photos you didn’t own on the internet a while ago, and now someone–possibly an artist, possibly a copyright troll–can file for damages of up to $30,000. Scam, you think, and toss the paper. Unfortunately for you, those copyright infringement proceedings were real, and now a government entity unbeknownst to you–something called the Copyright Claims Board–has determined, without judge or jury, that you owe this person $30,000.

Total Records: 182